Media events and presentations
This section features resources from sanofi-aventis events at major European and international medical conferences.
You can access webcasts of press conferences, investigator interviews and speaker biographies grouped under the relevant medical congress. Please click below to access the latest medical meetings.
This section features resources from sanofi-aventis events at major European and international medical conferences.
You can access webcasts of press conferences, investigator interviews and speaker biographies grouped under the relevant medical congress. Please click below to access the latest medical meetings.
November 01, 2008
Tackling Atrial Fibrillation and Associated Cardiovascular Risk Annual AHA Congress 2008, New Orleans – sanofi-aventis press conference
RecordAF Registry Baseline Data and New Data from the
Landmark ATHENA Study
Landmark ATHENA Study
September 03, 2008
The Effect of Dronedarone on Strokei and Other Cardiovascular Outcomes in Patients with Atrial Fibrillation
Update from the Landmark ATHENA Study. Annual ESC Congress 2008, Munich, sanofi-aventis press conference
Update from the Landmark ATHENA Study. Annual ESC Congress 2008, Munich, sanofi-aventis press conference
Annual ESC Congress 2008, Munich
ESC Industry Press Room, Press Centre West, 2nd Floor
ESC Industry Press Room, Press Centre West, 2nd Floor
May 15, 2008
First results of the ATHENA study: Dronedarone (Multaq®) in the management of Atrial Fibrillation.
Heart Rhythm 2008, the Heart Rhythm Society's 29th Annual Scientific Sessions, San Francisco, USA.
Heart Rhythm 2008, the Heart Rhythm Society's 29th Annual Scientific Sessions, San Francisco, USA.
Latest videos
The True Cost of Atrial Fibrillation
